© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 28, 2021
The COVID-19 pandemic has exacerbated the "hidden epidemic” of drug diversion. The good news is that health care systems are recognizing the need to switch to a more proactive approach.
May 17, 2021
More than a year into the COVID-19 pandemic, the mental health burden resulting from the public health crisis is becoming more and more apparent.
May 12, 2021
Pharmacist inclusion in stroke interventions improves patient outcomes.
May 04, 2021
More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.
April 30, 2021
Patrick Yoder, PharmD, founder and CEO of LogicStream Health, discusses the benefits of implementing AI tools for improving drug diversion processes.
April 28, 2021
The FDA has granted priority review to Axsome Therapeutics’ dextromethorphan-bupropion (AXS-05) for the treatment of major depressive disorder.
April 22, 2021
Patrick Yoder, PharmD, discusses the impacts of the impending ASHP guideline updates, how to build drug diversion processes, and the ways that technology can target drug diversion.
April 21, 2021
In the first part of our interview, Dr. Charles Lee will explain what this new Oregon law stipulates, the significance of this legislation, and some of the consequences of medication errors due to patient language barriers.
April 14, 2021
Oncology programs provide the tools needed to improve patient outcomes.
March 26, 2021
NCPA applauded the Michigan’s House passage of the legislation, which would reform many PBM reimbursement practices in the state.